https://www.gosh.nhs.uk/news/chief-medical-officer-takes-up-new-role-at-barts-health/
Chief Medical Officer takes up new role at Barts Health
22 Nov 2024, noon
Professor Sanjiv Sharma will be leaving Great Ormond Street Hospital (GOSH) to take up the new role of Group Chief Medical Officer for Barts Health NHS Trust. He will take up the role in March 2025.
This appointment builds on his clinical leadership experience at GOSH and extends it across a group of five hospitals ranging from highly specialised tertiary services to community settings.
Sanjiv joined the Hospital in 2004 as registrar and became a substantive consultant intensivist in 2010. Since then has had various leadership roles at GOHS, including Specialty Lead, and then Deputy Medical Director and Chief Medical Officer. Most recently he has been our Deputy Chief Executive.
Matthew Shaw, CEO, said: “Sanjiv is a phenomenal leader and I am sure will thrive in this new role. As our Chief Medical Officer and more latterly Deputy Chief Executive, he has led a wide range of strategic programmes and transformation work. He has been a national advocate for specialist paediatric services and patient safety.
“I personally would like thank him for all he has done for the organisation and his decades of service to the children and young people at GOSH.”
Sanjiv said: “After being at GOSH for so many years and working towards supporting children’s health and care it is sad to be leaving but I am excited at the prospective of joining Barts Health.
"Here I hope to be able to use my experience to support patient care in an even larger and more broad setting. I have been lucky to have worked with so many talented people and great teams at GOSH and I look forward to being able to support them in a different way in the future.”
Great Ormond Street Hospital joins the Circular Economy Healthcare Alliance (CEHA)
By joining CEHA, Great Ormond Street Hospital reaffirms its commitment to ‘do no harm’—not only to our patients, but to the environment and future generations.
‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia
A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer
NHS genetic testing gives ‘power’ to families with rare conditions
A new study has shown that whole genome sequencing, now offered as part of NHS care, allows children with rare conditions to access the right care faster.
GOSH Neonatal teams excelling in family-centred care
GOSH NICU has been awarded Bliss Baby Charter Silver Accreditation - a prestigious recognition of excellence in family-centred care.